| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 2 | -1.36M | 100% | $31.54 | -$42.7M |
| Net | -2 | -1.36M | -100% | -$42.7M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Decheng Capital Global Life Sciences Fund IV, L.P. | 10%+ Owner | $175M | Jan 29, 2024 | ||
| Hong Fang Song | Director | $118M | -$42.6M | -26.6% | Dec 16, 2024 |
| Leonard Post | Director | $0 | -$150K | -100% | Mar 17, 2025 |
| James Mulay | Director | Oct 4, 2024 | |||
| Brian Liu | Director | Oct 4, 2024 | |||
| Victor Edward Tong Jr | Director | Oct 4, 2024 | |||
| Susan E. Graf | Director | Oct 4, 2024 | |||
| Vijay Kasturi | Chief Medical Officer | Apr 15, 2025 | |||
| Corleen Roche | Cfo | Apr 15, 2025 | |||
| Arthur Kuan | Chief Executive Officer, Director | Apr 15, 2025 | |||
| Joshua F. Patterson | General Counsel and Chief Compliance Officer | Apr 15, 2025 | |||
| Ambaw Bellete | President and COO | Apr 15, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|